Key result
Higher maximal inspiratory pressure is linked to ~35% lower 2-year mortality in older HF patients.
Why the study?
Does adding maximal inspiratory pressure (PImax) to established physical function assessments (SPPB, gait speed, handgrip strength) improve prediction and risk reclassification of 2-year all-cause death in older patients with heart failure?
Cohort (n=258)
No
Does adding maximal inspiratory pressure (PImax) to established physical function assessments (SPPB, gait speed, handgrip strength) improve prediction and risk reclassification of 2-year all-cause death in older patients with heart failure?
Measuring maximal inspiratory pressure at discharge captures HF-specific respiratory muscle dysfunction and significantly improves 2-year mortality risk reclassification beyond standard extremity physical function tests in older HF patients.
Answers are grounded in this paper and cite their sources.
PImax may enhance risk stratification beyond SPPB in older HF; extends physical function data but leaves open routine clinical adoption.
Background: In older patients with heart failure (HF), the Short Physical Performance Battery (SPPB), gait speed, and handgrip strength are recognized prognostic markers. However, whether adding maximal inspiratory pressure (PImax) to these assessments provides incremental prognostic value remains unclear. Methods and Results: This single-center, retrospective cohort study included 258 older patients with HF (mean age, 81.1±7.0 years; 56.2% men) discharged between April 2021 and March 2025. SPPB, comfortable gait speed, handgrip strength, PImax, and maximal expiratory pressure were measured at discharge. Multivariable Cox regression was adjusted for the MAGGIC risk score and log-transformed B-type natriuretic peptide. Within 2 years, 42 patients (16.3%) died. PImax (hazard ratio [HR] 0.65; 95% confidence interval [CI], 0.53–0.80; P<0.001), SPPB (HR 0.88; 95% CI, 0.82–0.95; P<0.001), and comfortable gait speed (HR 0.85; 95% CI, 0.77–0.95; P=0.003) were independently associated with all-cause death. Only PImax remained independent when entered with SPPB (HR 0.70; 95% CI, 0.56–0.87; P<0.001). Although adding PImax to the SPPB-based model did not significantly improve the C-index (0.020; 95% CI, −0.017 to 0.056; P=0.294), it significantly improved reclassification (integrated discrimination improvement 0.061; 95% CI, 0.015–0.132; P=0.008; net reclassification improvement 0.478; 95% CI, 0.124–0.920; P=0.004). Conclusions: PImax was independently associated with 2-year all-cause death in older patients with HF, and its addition to established physical function assessments may improve risk reclassification.
No takes yet. Share an insight, caveat, or question.
Yoshii et al. (2026) conducted a cohort in Heart Failure (n=258). Maximal inspiratory pressure (PImax) vs. Established physical function assessments (SPPB, comfortable gait speed, handgrip strength) was evaluated on All-cause death within 2 years after discharge (HR 0.65, 95% CI 0.53–0.80, p=<0.001). Maximal inspiratory pressure was independently associated with 2-year all-cause death (HR 0.65, 95% CI 0.53-0.80, P<0.001) and improved risk reclassification beyond SPPB in older HF patients.
Synapse has enriched 10 related papers. Consider them for comparative context: